Back to Trades
Erdogan-Trinkaus Ipek
Chief Commercial OfficerCIK 0002047026
Total Volume
$974.6K
4 filings
Purchases
$0
0 buy txns
Sales
$235.9K
2 sell txns
Net Activity
-$235.9K
net sold
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 4
- Buy transactions
- 0
- Sell transactions
- 2
- Companies
- 1
- Active
- 2025–2026
Erdogan-Trinkaus Ipek, Chief Commercial Officer, accounts for 4 disclosed filings worth $974.6K, all concentrated in Eton Pharmaceuticals, Inc. (ETON), active 2025–2026. The record is heavily weighted toward selling, with $0 in purchases against $235.9K in sales. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
4 loaded
| Nov 12 | ETON Eton Pharmaceuticals, Inc. | Erdogan-Trinkaus Ipek | Chief Commercial Officer | Sell | $235.9K |
| Aug 4 | ETON Eton Pharmaceuticals, Inc. | Erdogan-Trinkaus Ipek | Chief Commercial Officer | Award | $0 |
| Jan 14 | ETON Eton Pharmaceuticals, Inc. | Erdogan-Trinkaus Ipek | Chief Commercial Officer | Award | $628.9K |
| Dec 12 | ETON Eton Pharmaceuticals, Inc. | Erdogan-Trinkaus Ipek | Chief Commercial Officer | Tax withheld | $1.4K |
4 filings